Condition: Chronic Primary Immune Thrombocytopenia (ITP) · Sponsor: Kedrion S.p.A.
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP
This description comes directly from the study's public registry record.
Anna Lotti Suffredini · +39 338 6827568 · a.lotti@kedrion.com
Linda Karpiak · 973-216-0484 · l.karpiak@kedrion.com
Always discuss trial participation with your own doctor first.
| University of Southern California | Los Angeles, California, United States | Recruiting |
| NY Cancer and Blood Specialists | Shirley, New York, United States | Recruiting |
| East Carolina University | Greenville, North Carolina, United States | Recruiting |
| Vseobecna Fakultni Nemocnice v Praze | Prague, Prague, Czechia | Recruiting |
| Fakultni Nemocnice Brno | Brno, South Moravian, Czechia | Recruiting |
| Onkologisches Zentrum Donauwörth Neudegger - Onkomedeor Onkologische Zentren | Donauwörth, Bavaria, Germany | Withdrawn |
| Universitätsklinikum Frankfurt | Frankfurt am Main, Hesse, Germany | Recruiting |
| Azienda Ospedaliero - Universitaria Careggi | Florence, Florence, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara | Novara, Novara, Italy | Recruiting |
| Azienda Sanitaria Universitaria Giuliano Isontina | Trieste, Trieste, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino | Torino, Turin, Italy | Recruiting |
| AULSS 8 Berica - Ospedale San Bortolo Di Vicenza | Vicenza, Vicenza, Italy | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07059000